Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

OTHER 3 NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Specimen Handling 7 Magnetic Resonance Spectroscopy 7 Radiotherapy 5 Biopsy 4 Radiation 3 High-Energy Shock Waves 3 Cyclophosphamide 3 venetoclax 2 X-Rays 2 Vincristine 2 Spinal Puncture 2 Sentinel Lymph Node Biopsy 2 Radiosurgery 2 Paclitaxel 2 Daunorubicin 2 Cytarabine 2 Azacitidine 2 trastuzumab deruxtecan 1 trastuzumab biosimilar HLX02 1 taxane 1 sulforaphane 1 sacituzumab govitecan 1 revumenib 1 prednylidene 1 pertuzumab 1 pembrolizumab 1 pegaspargase 1 nelarabine 1 merphos 1 liposomal doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × NETWORK × Lidocaine × Clear all

NCT07347977 2026-01-16

LidCRM

First Affiliated Hospital of Ningbo University

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡